# AstraZeneca vs UnitedHealth Group: stocks compared

URL: https://funkfolio.com/compare/azn-vs-unh

> AstraZeneca ($282.7B, P/E 25.8) and UnitedHealth Group ($349.2B, P/E 22.2) compared: size, valuation, margins, debt, cash and price change.

---

## AstraZeneca vs UnitedHealth Group

AstraZeneca (AZN), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

UnitedHealth Group is worth $349.2B on the stock market and AstraZeneca $282.7B: UnitedHealth Group is valued at 24% more. AstraZeneca trades at 25.8 times earnings and UnitedHealth Group at 22.2; operating margins in their latest fiscal years were 23.4% and 4.24%. Over the past year AstraZeneca's share price has moved +2.75% and UnitedHealth Group's +31.4%.

### Key facts

- **AstraZeneca market value:** $282.7B
- **UnitedHealth Group market value:** $349.2B
- **AstraZeneca P/E:** 25.8
- **UnitedHealth Group P/E:** 22.2
- **AstraZeneca revenue:** $58.7B FY to 2025-12-31
- **UnitedHealth Group revenue:** $447.6B FY to 2025-12-31
- **Superinvestors holding both:** 8

Market values as of 18 Nov 2026, 09:29 UTC.

AstraZeneca vs UnitedHealth Group: every measure side by side

| Measure | AstraZeneca | UnitedHealth Group |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United Kingdom | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $282.7B lower | $349.2B higher |
| Revenue | $58.7B lower | $447.6B higher |
| Earnings | $10.2B lower | $12.1B higher |
| Employees | 96,100 lower | 390,000 higher |
| Total assets | $114.1B lower | $309.6B higher |
| Valuation |  |  |
| P/E | 25.8 higher | 22.2 lower |
| P/S | 4.8 higher | 0.8 lower |
| P/B | — | 3.6 |
| Dividend yield | — | 2.20% |
| Profitability |  |  |
| Operating margin | 23.4% higher | 4.24% lower |
| Balance sheet |  |  |
| Net assets | $48.7B lower | $100.1B higher |
| Total liabilities | $65.4B lower | $207.9B higher |
| Total debt | $29.6B lower | $77.7B higher |
| Cash on hand | $5.7B lower | $24.4B higher |
| Price change |  |  |
| Today | -0.95% higher | -5.42% lower |
| 1 year | +2.75% lower | +31.4% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: AstraZeneca 101.9, UnitedHealth Group 121.6.

- AstraZeneca (AZN)
- UnitedHealth Group (UNH)

AstraZeneca and UnitedHealth Group share prices over one year, rebased to 100: AstraZeneca ends at 101.9, UnitedHealth Group at 121.6.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | AZN | UNH |
| --- | --- | --- |
| Nov 28, 2025 | 103.7 | 102.9 |
| Dec 31, 2025 | 102.8 | 103.0 |
| Jan 30, 2026 | 103.8 | 89.5 |
| Feb 27, 2026 | 116.6 | 91.5 |
| Mar 31, 2026 | 110.3 | 84.4 |
| Apr 30, 2026 | 104.8 | 115.6 |
| May 29, 2026 | 103.8 | 118.7 |
| Jun 30, 2026 | 106.1 | 129.7 |
| Jul 31, 2026 | 94.9 | 129.3 |
| Aug 31, 2026 | 90.7 | 121.5 |
| Sep 30, 2026 | 90.3 | 114.5 |
| Oct 30, 2026 | 104.4 | 127.0 |
| Nov 17, 2026 | 101.9 | 121.6 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (8)

- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 20.2% / 0.3%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 1.1% / 2.0%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.5% / 1.1%
- [Temasek](https://funkfolio.com/gurus/temasek) 0.4% / 0.5%
- [Andrew Spokes](https://funkfolio.com/gurus/farallon) 0.4% / 2.0%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2% / 0.5%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) &lt;0.1% / 1.6%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) &lt;0.1% / 0.8%

#### AstraZeneca only (4)

- [Primecap team](https://funkfolio.com/gurus/primecap) 1.8%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 1.1%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 0.7%
- [Polen Capital team](https://funkfolio.com/gurus/polen-capital) &lt;0.1%

#### UnitedHealth Group only (21)

- [Samantha McLemore](https://funkfolio.com/gurus/samantha-mclemore) 5.2%
- [Sequoia Fund team](https://funkfolio.com/gurus/sequoia-fund) 4.2%
- [Bill Smead](https://funkfolio.com/gurus/bill-smead) 2.5%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 2.2%
- [Christopher Davis](https://funkfolio.com/gurus/christopher-davis) 2.0%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) 1.7%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 1.4%
- [Pat English](https://funkfolio.com/gurus/pat-english) 1.4%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 1.1%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.0%
- [Duan Yongping](https://funkfolio.com/gurus/duan-yongping) 0.9%
- [Stephen Yacktman](https://funkfolio.com/gurus/stephen-yacktman) 0.8%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.5%
- [Chase Coleman](https://funkfolio.com/gurus/chase-coleman) 0.5%
- [C.T. Fitzpatrick](https://funkfolio.com/gurus/ct-fitzpatrick) 0.5%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.5%
- [Robert Pitts](https://funkfolio.com/gurus/robert-pitts) 0.4%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.3%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.1%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": AstraZeneca / UnitedHealth Group). [Who owns AZN](https://funkfolio.com/stock/AZN/superinvestors) · [Who owns UNH](https://funkfolio.com/stock/UNH/superinvestors)

### More on AstraZeneca

- [AstraZeneca (AZN) stock page](https://funkfolio.com/stock/AZN)
- [AstraZeneca market cap](https://funkfolio.com/stock/AZN/market-cap)
- [AstraZeneca revenue](https://funkfolio.com/stock/AZN/revenue)
- [AstraZeneca P/E ratio](https://funkfolio.com/stock/AZN/pe-ratio)
- [AstraZeneca operating margin](https://funkfolio.com/stock/AZN/operating-margin)
- [AstraZeneca total debt](https://funkfolio.com/stock/AZN/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on UnitedHealth Group

- [UnitedHealth Group (UNH) stock page](https://funkfolio.com/stock/UNH)
- [UnitedHealth Group market cap](https://funkfolio.com/stock/UNH/market-cap)
- [UnitedHealth Group revenue](https://funkfolio.com/stock/UNH/revenue)
- [UnitedHealth Group P/E ratio](https://funkfolio.com/stock/UNH/pe-ratio)
- [UnitedHealth Group operating margin](https://funkfolio.com/stock/UNH/operating-margin)
- [UnitedHealth Group total debt](https://funkfolio.com/stock/UNH/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### AstraZeneca against its closest peers

- [AstraZeneca vs Novartis](https://funkfolio.com/compare/azn-vs-nvs)
- [AstraZeneca vs Thermo Fisher Scientific](https://funkfolio.com/compare/azn-vs-tmo)
- [AstraZeneca vs Merck & Co](https://funkfolio.com/compare/azn-vs-mrk)

#### UnitedHealth Group against its closest peers

- [UnitedHealth Group vs Merck & Co](https://funkfolio.com/compare/mrk-vs-unh)
- [UnitedHealth Group vs Novartis](https://funkfolio.com/compare/nvs-vs-unh)
- [UnitedHealth Group vs AbbVie](https://funkfolio.com/compare/abbv-vs-unh)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, AstraZeneca or UnitedHealth Group?**

By market value, UnitedHealth Group is the larger: $349.2B against $282.7B for AstraZeneca. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $58.7B for AstraZeneca.

**Which has the higher P/E ratio?**

AstraZeneca: 25.8, against 22.2 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

AstraZeneca: 23.4%, against 4.24% for UnitedHealth Group. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

UnitedHealth Group: $77.7B, against $29.6B for AstraZeneca. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both AstraZeneca and UnitedHealth Group?**

In their latest 13F filings, Sarah Ketterer, Lew Sanders, Ken Fisher, Temasek, Andrew Spokes, Steve Cohen, Dodge & Cox team and Rajiv Jain hold both.

### Cite this page

Funkfolio, “AstraZeneca vs UnitedHealth Group”, data as of 18 November 2026. https://funkfolio.com/compare/azn-vs-unh

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
